Postmenopausal drug does not promote breast cancer, study confirms
Breast cancer is a major concern for many aging women in the U.S., whose doctors may recommend that they buy Tamoxifen to prevent the progression of the disease.
Breast cancer is a major concern for many aging women in the U.S., whose doctors may recommend that they buy Tamoxifen to prevent the progression of the disease. Recently, a study reported at the Women's Congress 2011 annual meeting revealed that Natural S-equol - a soy-based compound that is often used to manage menopause symptoms - does not increase the risk of breast cancer.
Research companies Pharmavite and Otsuka Pharmaceutical reported that they had conducted the study in a population of mice with breast cancer. They divided the animals into two groups, feeding one with Natural S-equol and the other with a normal laboratory diet. Due to similar tumor sizes in the two sets of mice, the researchers concluded that Natural S-equol does not increase the progression of these cancerous growths.
"These new data enhance our understanding of the safety of Natural S-equol because they document that [the treatment] did not increase or stimulate the growth of mammary tumors in mice, using a well-known animal model," said scientist Belinda H. Jenks.
These promising results may have positive implications for women who take the remedy to manage their menopause symptoms.
Buying these and other cheap medications from Canada can help them find significant discounts on the treatments they need.
|
